Securities code: 603067 securities abbreviation: Hubei Zhenhua Chemical Co.Ltd(603067) Announcement No.: 2022-004
Hubei Zhenhua Chemical Co.Ltd(603067)
Announcement on the reduction of shares by shareholders holding more than 5% to 1% through block trading
The board of directors and all directors of the company guarantee that there are no false records and misleading statements in the contents of this announcement
Or major omissions, and bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents.
Important content tips:
Before this equity change, Hubei Zhenhua Chemical Co.Ltd(603067) (hereinafter referred to as “the company”) held
Chongqing chemical medicine holding (Group) Co., Ltd. (hereinafter referred to as “chemical medicine group”) holds more than 5% of the company’s shares
67836166 tradable shares without restrictions, accounting for 13.34% of the total share capital of the company;
After this equity change, the chemical medicine group holds 57676166 tradable shares of the company without sale conditions,
Accounting for 11.34% of the total share capital of the company;
The reduction of this block transaction does not belong to the situation that the reduction plan needs to be disclosed in advance.
1、 Basic information of this equity change
On February 11, 2022, the company received the notice of shareholders holding more than 5% of shares on reducing their holdings from the shareholder of chemical medicine group
The notification letter that the shares reached 1% was passed by the chemical medicine group on February 10, 2022 due to capital needs
10160000 shares of the company were reduced in this transaction, accounting for 1.9984% of the total share capital of the company. The specific circumstances are as follows:
Below:
Quantity of reduction and average price of reduction
Shareholder name reduction method share type reduction proportion during reduction period (share) (yuan / share)
Chongqing chemical medicine holding RMB ordinary, February 2022
Block trading 10160000 11.69 1.9984% (Group) company shares (A shares) 10 days
2、 Shares held by chemical medicine group before and after this equity change
Shares held before this change shares held after this change
Name of shareholder nature of shares in total share capital in total share capital
Number of shares (shares)
Proportion proportion
Chongqing chemical medicine holding limited circulation conditions 67836166 13.34% 57676166 11.34%
(Group) company shares (A shares)
Note: all the shares of the company held after this equity change enjoy voting rights, and there is no restriction or restricted transfer of voting rights, such as delegation or restriction of voting rights.
3、 Description of other matters
1. The reduction did not violate the provisions of the securities law, the Listing Rules of Shanghai Stock Exchange, several provisions on the reduction of shares held by major shareholders, directors, supervisors and senior managers of listed companies, the implementation rules for the reduction of shares held by shareholders, directors, supervisors and senior managers of listed companies on Shanghai Stock Exchange and other relevant laws, regulations and normative documents, The reduction of chemical medicine group’s holdings in this block transaction does not belong to the situation that the reduction plan needs to be disclosed in advance.
2. Chemical medicine group is not the controlling shareholder or actual controller of the company. This change in equity will not lead to changes in the controlling shareholder and actual controller of the company, and will not have a significant impact on the corporate governance structure, equity structure and sustainable operation.
3. This change in shareholders’ equity does not involve the disclosure of equity change report by the information disclosure obligor. The company will perform the obligation of information disclosure in a timely manner in strict accordance with the provisions and requirements of relevant laws and regulations. Please pay attention to investment risks.
It is hereby announced.
Hubei Zhenhua Chemical Co.Ltd(603067) board of directors February 14, 2022
